Phase I clinical trial safety of DNA- and modified virus Ankara-vectored human immunodeficiency virus type 1 (HIV-1) vaccines administered alone and in a prime-boost regime to healthy HIV-1-uninfected volunteers
- 23 January 2006
- Vol. 24 (4), 417-425
- https://doi.org/10.1016/j.vaccine.2005.08.041